Accolade, Inc. (ACCD) Financials
ACCD Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2024-02-29 | 788.2 million | 342.7 million |
2023-11-30 | 785.5 million | 350.8 million |
2023-08-31 | 854.3 million | 416.7 million |
2023-05-31 | 875.7 million | 421.5 million |
ACCD Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2024-02-29 | 3.8 million | 15.3 million |
2023-11-30 | 1.5 million | 15.6 million |
2023-08-31 | -11.3 million | 15.7 million |
2023-05-31 | -22.7 million | 14.3 million |
ACCD Net Income
No data available :(
ACCD Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2024-02-29 | 237.0 million | - | 32.7 million |
2023-11-30 | 230.0 million | - | 33.5 million |
2023-08-31 | 292.2 million | - | 30.6 million |
2023-05-31 | 302.9 million | - | 32.7 million |
ACCD Shares Outstanding
ACCD Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2024-02-29 | 2.1 million | 24.2 million | 14.3 million | 24.7 million |
2023-11-30 | 3.7 million | 23.5 million | 15.5 million | 26.2 million |
2023-08-31 | 3.3 million | 25.6 million | 16.3 million | 24.1 million |
2023-05-31 | 3.4 million | 25.9 million | 16.1 million | 25.0 million |
ACCD Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2024-02-29 | 124.8 million | 70.5 million |
2023-11-30 | 99.4 million | 54.5 million |
2023-08-31 | 96.9 million | 55.3 million |
2023-05-31 | 93.2 million | 54.2 million |
ACCD
Price: $7.12
52 week price:
Earnings Per Share: -1.62 USD
P/E Ratio: -8.02
Exchange: NMS
Sector: Healthcare
Industry: Health Information Services
Volume: 1.5 million
Market Capitalization: 597.9 million